The consumption of dietary supplement in Western Europe is estimated to expand at a promising CAGR of 8.2% through 2033. The sales of dietary supplement in Western Europe are expected to reach a valuation of USD 35,578.05 million by 2033, up from 16,185.60 in 2023.
Western Europe holds significant potential for manufacturers to expand their business operations. Consequently, they are diversifying their product lines, covering broader segment such as sports and energy, joint health, liver and detox, mental health, etc., to attract more customers. Additionally, leading competitors are fostering intense competition in the region by innovating more complex dietary supplement.
Attributes | Details |
---|---|
Industry Size of Dietary Supplement in Western Europe (2023) | USD 16,185.60 million |
Expected Industry Size of Dietary Supplement in Western Europe (2033) | USD 35,578.05 million |
Forecast CAGR between 2023 to 2033 | 8.2% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Country | Italy |
---|---|
Forecast CAGR % (2023 to 2033) | 6.70% |
Consumption rate of dietary supplement in Italy is predicted to register a CAGR of 6.70% through 2033. Following factors are appreciating the industry worth in Italy:
Country | Germany |
---|---|
Forecast CAGR % (2023 to 2033) | 5.80% |
The adoption of dietary supplement in Germany is increasing at a speed of 5.80 % CAGR through 2033. Given below are the leading factors that are pushing the sales of dietary supplement:
Country | United Kingdom |
---|---|
Forecast CAGR % (2023 to 2033) | 7.90% |
Sales of dietary supplement in the United Kingdom are predicted to expand at a CAGR of 7.90% through 2033. Following factors support product sales in this country:
Country | The Netherlands |
---|---|
Forecast CAGR % (2023 to 2033) | 7.10% |
Consumption of dietary supplement in the Netherlands is expected to surge at a CAGR of 7.10% through 2033. Mentioned below are the leading factors inducing sales of dietary supplement:
Country | France |
---|---|
Forecast CAGR % (2023 to 2033) | 6.30% |
The adoption rate of dietary supplement in France is predicted to record a CAGR of 6.30% through 2033. The following factors augment the sales of dietary supplement:
Leading Form | Soft Gel/ Pills |
---|---|
Value Share % (2023) | 57.80% |
The soft gels/pills segment accounts for a value share of 57.80% in 2023. The segment's growth is driven by the availability of a variety of multivitamin options in the form of soft gels and capsules. Their user-friendly format and easy consumption contribute to the increasing demand for soft gels and pills. Consumers, especially those with swallowing issues, favor soft gels and pills due to their effortless swallowability and gel-like consistency.
Cost-effectiveness, extended shelf life, and convenient packaging of soft gels and capsule supplement are also enhancing the segment's growth. Soft gels and capsules feature well-defined dosages, differentiating them from liquid dietary supplement and contributing to their greater prevalence in Europe.
Leading Ingredient | Amino Acids |
---|---|
Value Share % (2023) | 41.70% |
As per our study, amino acids account for a share of 41.70% in 2023. Amino acids are recommended for patients suffering from chronic disorders like heart disease, diabetes, and cancer, as these diseases typically have a debilitating effect on the body’s ability to absorb and utilize amino acids. Additionally, the growing popularity of sports and fitness in Western Europe is fueling the consumption of amino acid supplement among athletes and gym-goers.
Private enterprises, as well as public corporations in Western Europe, are intensifying their commitment to innovation and quality, both of which are crucial to ensuring brand reputation. Leading players are emphasizing the improvement of their product offerings. In addition to this, companies are dedicating their research and development efforts to seamlessly integrate cutting-edge technologies, reflecting their dedication to providing high-quality dietary supplement.
Key Development Spurring the Sales of Dietary Supplement in Western Europe
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Attribute | Details |
---|---|
Estimated Industry Size in 2023 | USD 16,185.60 million |
Projected Industry Size by 2033 | USD 35,578.05 million |
Anticipated CAGR between 2023 to 2033 | 8.2% CAGR |
Historical Analysis of Demand for Dietary Supplement in Western Europe | 2018 to 2022 |
Demand Forecast for Dietary Supplement in Western Europe | 2023 to 2033 |
Report Coverage of Dietary Supplement in Western Europe | Industry Size, Industry Trends, Analysis of Key Factors Influencing Dietary Supplement Adoption in Western Europe, Insights on Western Europe Players and their Industry Strategy in Western Europe, Ecosystem Analysis of Local and Regional Western Europe Providers |
Key Countries Analyzed While Studying Opportunities for Dietary Supplement in Western Europe | Germany, Italy, France, United Kingdom, Spain, The Netherlands, BENELUX, Rest of Western Europe |
Key Companies Profiled for Dietary Supplement in Western Europe | GlaxoSmithKline plc; Bayer AG; Reckitt Benckiser Group PLC; Amway Corporation; Abbott Nutrition; Others |
The anticipated CAGR through 2033 is 8.2%.
Demand for dietary supplement in Western Europe is expected to reach USD 35,578.05 million by 2033.
Manufacturers are turning to investment strategy to compete in the region.
Soft gels/pills is prominently consumed by population in Western Europe.
Amino acids take a considerable share of the dietary supplement industry.
1. Executive Summary 2. Market Overview 3. Market Background 4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033 5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Ingredients 5.1. Amino Acid 5.2. Animal Extract 5.3. Botanical Extract 5.4. Mineral 5.5. Nucleotide 5.6. Omega 3 5.7. Probiotics 5.8. Protein 5.9. Sugar 5.10. Vegetable Oil & Powder 5.11. Vitamin 5.12. Yeast Extract 6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Form 6.1. Soft Gel/Pills 6.1.1. Confectionery Products 6.1.2. Pharmaceuticals Products 6.2. Powder 6.3. Liquid 7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Weight Loss 7.2. Sports Nutrition’s 7.3. General Well-Beings 7.4. Immune & Digestive Health 7.5. Bone & Joint Health 7.6. Heart Health 7.7. Others Specific Requirements (Supplements, Anti-Allergies & Eye Health) 8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. UK 8.2. Germany 8.3. Italy 8.4. France 8.5. Spain 8.6. Rest of Western Europe 9. UK Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 10. Germany Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 11. Italy Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 12. France Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 13. Spain Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region 14. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033 15. Market Structure Analysis 16. Competition Analysis 16.1. Amway Corp. 16.2. Glanbia PLC 16.3. Abbott 16.4. Bayer AG 16.5. Pfizer Inc. 16.6. ADM 16.7. Nu Skin Enterprises, Inc. 16.8. GlaxoSmithKline plc 16.9. Bionova 16.10. Ayanda 16.11. Arkopharma 17. Assumptions & Acronyms Used 18. Research Methodology
Explore Food and Beverage Insights
View Reports